We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
Summary
This review explores the connection between type 2 diabetes and Parkinson's disease through shared inflammatory pathways involving the NF-kB and NLRP3 inflammasome systems. High blood sugar in diabetes triggers inflammation and oxidative stress that may damage dopamine-producing brain cells, increasing Parkinson's risk. While not directly about microplastics, these inflammatory pathways are the same ones that microplastic exposure has been shown to activate in other studies.
Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease (AD). Genetic predisposition and immune dysfunction are involved in the pathogenesis of PD. Notably, peripheral inflammatory disorders and neuroinflammation are associated with PD neuropathology. Type 2 diabetes mellitus (T2DM) is associated with inflammatory disorders due to hyperglycaemia-induced oxidative stress and the release of pro-inflammatory cytokines. Particularly, insulin resistance (IR) in T2DM promotes the degeneration of dopaminergic neurons in the substantia nigra (SN). Thus, T2DM-induced inflammatory disorders predispose to the development and progression of PD, and their targeting may reduce PD risk in T2DM. Therefore, this narrative review aims to find the potential link between T2DM and PD by investigating the role of inflammatory signalling pathways, mainly the nuclear factor kappa B (NF-κB) and the nod-like receptor pyrin 3 (NLRP3) inflammasome. NF-κB is implicated in the pathogenesis of T2DM, and activation of NF-κB with induction of neuronal apoptosis was also confirmed in PD patients. Systemic activation of NLRP3 inflammasome promotes the accumulation of α-synuclein and degeneration of dopaminergic neurons in the SN. Increasing α-synuclein in PD patients enhances NLRP3 inflammasome activation and the release of interleukin (IL)-1β followed by the development of systemic inflammation and neuroinflammation. In conclusion, activation of the NF-κB/NLRP3 inflammasome axis in T2DM patients could be the causal pathway in the development of PD. The inflammatory mechanisms triggered by activated NLRP3 inflammasome lead to pancreatic β-cell dysfunction and the development of T2DM. Therefore, attenuation of inflammatory changes by inhibiting the NF-κB/NLRP3 inflammasome axis in the early T2DM may reduce future PD risk.
Sign in to start a discussion.
More Papers Like This
Micro-nanoplastics and Parkinson’s disease: evidence and perspectives
Researchers reviewed growing evidence linking micro- and nanoplastic exposure to Parkinson's disease, a degenerative brain condition. Lab studies suggest these particles may accelerate disease by promoting the misfolding of a key brain protein (alpha-synuclein), triggering inflammation, and damaging mitochondria — though large-scale human studies are still needed to establish causation and define safe exposure thresholds.
The role of microplastics exposure in Alzheimer’s and Parkinson’s disease
Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
This review explores the emerging connection between microplastic exposure and neurodegenerative diseases such as Alzheimer's and Parkinson's, identifying shared pathophysiological pathways. Researchers found that microplastics can cross the blood-brain barrier and may trigger oxidative stress, neuroinflammation, and protein aggregation, which are hallmarks of these conditions. The study suggests that chronic microplastic exposure could be a contributing environmental factor in neurodegeneration, though direct causal evidence in humans is still lacking.
Exploring the micro- and nanoplastics–diabetes nexus: Shattered barriers, toxic links, and methodological horizons
This review examines growing evidence that micro- and nanoplastics may contribute to diabetes by disrupting blood sugar regulation, insulin signaling, and fat metabolism through oxidative stress and inflammation. Animal studies show that plastic particles can damage the pancreas, liver, and gut in ways that mirror the development of diabetes, though human studies are still limited. The review calls for more research into whether everyday microplastic exposure could be a hidden factor in the global rise of metabolic diseases.
Microplastic Exposure and the of Parkinson’s Disease
This review examines evidence linking microplastic exposure to Parkinson's disease pathology, noting that animal studies show microplastics can decrease dopaminergic neurons and impair motor function through mechanisms resembling the disease's progression.